333
Participants
Start Date
January 16, 2014
Primary Completion Date
December 31, 2021
Study Completion Date
December 31, 2021
AZD2014
Oral tablet
Everolimus
Oral tablet
Fulvestrant
Im injection
ICO Paul Papin, Angers
Institut Sainte Catherine, Avignon
Antoine Lacassagne Centre De Lutte Contre Le Cancer De Nice, Nice
Hospital Center Private Saint-Grégoire, Saint-Grégoire
Centre Paul Strauss, Strasbourg
Clinic Health House, Tbilisi
Institute of Clinical Oncology, Tbilisi
S. Khechinashvili University Clinic, Tbilisi
Tbilisi Cancer Center, Tbilisi
Frauenärztliche Gemeinschaftspraxis - Onkologie, Braunschweig
Kliniken Essen-Mitte Senologie, Essen
Klinik für Gynäkologie & Geburtshilfe/Brustzentrum, Frankfurt
Praxis für interdisziplinäre Onkologie & Hämatologie, Freiburg im Breisgau
MediProjekt GbR Hannover, Hannover
SLK-Kliniken Heilbronn GmbH, Heilbronn
Dokusan GmbH, Herne
St. Vincentius Kliniken, Karlsruhe
Schwerpunktpraxis Hämatologie / Onkologie MVZ Lahr, Lahr
Klinikum Neumarkt, Neumarkt
Onkologische Praxis, Oldenburg
Praxis für Innere Medizin, Singen
MVZ Klinik Dr. Hancken GmbH, Stade
Mutterhaus der Borromäerinnen, Trier
Schwarzwald Baar Klinikum, Villingen-Schwenningen, Villingen-Schwenningen
Uzsoki Street Hospital, Budapest
Bacs-Kiskun County Hospital, Kalocsa
University of Pecs, Institute of Oncology, Pécs
Zala County Szent Rafael Hospital, Zalaegerszeg
Hospital da Luz, Lisbon
Ipo Porto, Porto
Center of Oncology Euroclinic, Bucharest
Oncology Center Sf Nectarie, Caracal
Cluj County Clinical Emergency Hospital, Clinical Department of Medical Oncology, Cluj-Napoca
"Oncology Institute Prof. Dr. Ion Chiricuta", Cluj-Napoca
Oncology Center Oncolab Craiova, Craiova
National Cancer Center South Korea, Goyang
Korea University Medical Center Guro Hospital, Seoul
Yonsei University Health System, Seoul
Hospital Universitari Vall D'Hebron, Barcelona
Instituto Oncologico Dr. Rosell, Barcelona
Consorcio Hospitalario Provincial de Castellon, Castelló
Cafeteria Hospital San Pedro de Alcantara, Cáceres
Hospital Ico Josep Trueta, Girona
University Hospital Arnau de Vilanova, Lleida
Hospital Clinico Universitario San Carlos, Madrid
Hospital Son Llàtzer, Palma
Hospital Son Espases, Palma de Mallorca
Hospital Universitario de Canarias, San Cristóbal de La Laguna
Hospital Universitari Sant Joan de Reus, Tarragona
Wansbeck General Hospital, Ashington
Princess of Wales Hospital, Bridgend
Royal Sussex County Hospital, Brighton
Kent and Canterbury Hospital, Canterbury
Cumberland Infirmary, Carlisle
Broomfield Hospital, Chelmsford
University Hospital of North Durham, Durham
Calderdale Royal Hospital, Halifax
Huddersfield Royal Infirmary, Huddersfield
Kidderminster Hospital, Kidderminster
Royal Glamorgan Hospital, Llantrisant
Charring Cross Hospital, London
King's College Hospital, London
Mount Vernon Hospital, London
Queen Elizabeth Hospital, Woolwich, London
Saint Bartholomew's Hospital, London
The Royal Free Hospital, London
The Kent Oncology Centre, Maidstone
North Tyneside General Hospital, North Shields
Nottingham City Hospital, Nottingham
Derriford Hospital, Plymouth
Weston Park Hospital, Sheffield
Solihull Hospital, Solihull
Southend University Hospital, Southend-on-Sea
Royal Stoke University Hospital, Stoke-on-Trent
King's Mill Hospital, Sutton in Ashfield
Great Western Hospital, Swindon
Wrexham Maelor, Wrexham
Yeovil District Hospital, Yeovil
Queen Mary University of London, London
Collaborators (1)
AstraZeneca
INDUSTRY
Queen Mary University of London
OTHER